Table 2.
Family Identificationa | Gene | Mode of Transmission | Nucleotide Change | Amino Acid Change | State | Evolutionary Conservationb | PP2 SIFT MT | CADD Score | EVSc | gnomADc | ACMGd | HGMDe | Phenotypes | Segregation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A617f | SALL1g | Dominant | c.703G>A | p.Ala 235Thr | Het | Danio rerio | 0.782 Del. D.C. | 18 | / | 0/3/277166 | Likely pathogenic | DM | Townes Brock syndrome | Variant inherited from father (affection status unknown) |
BL VUR R duplex | ||||||||||||||
A1041h | SRGAP1g | Dominant | c.1993C>A | p.Pro 665Thr | Het | Caenorhabditis elegans | 0.309 Del. D.C. | 24 | / | / | Pathogenic | DM | L horseshoe kidney | Variant inherited from mother (affection status unknown) |
R MCDK | ||||||||||||||
Cleft palate | ||||||||||||||
Intellectual disability | ||||||||||||||
A1147 | GATA3g | De novo dominant | c.708_709 insT | p.Ser 237Glnfs*67i | Het | — | / | NA | / | / | Pathogenic | Gene | BL VUR | De novo variant (paternity and maternity confirmed) |
Septate uterus | ||||||||||||||
Hearing loss | ||||||||||||||
Progressive renal impairment | ||||||||||||||
A1160j | Trisomy 20pg | De novo | — | / | / | L RA | De novo variant (paternity and maternity confirmed) | |||||||
Mitral regurgitation | ||||||||||||||
Hypotonia | ||||||||||||||
Intellectual disability | ||||||||||||||
A3346k | TRPS1g | Dominant | c.2795C>T | p.Ala 932Val | Het | Saccharomyces cerevisiae | 0.997 Del. D.C. | 21 | / | / | Likely pathogenic | DM | Trichorhinophalangeal syndrome | Variant inherited from affected father (trichorhinophalangeal syndrome) |
BL RHD, VUR | ||||||||||||||
A4450 | KMT2Dg | Dominant | c.6638G>A | p.Gly2213Asp | Het | Xenopus tropicalis | 0.186 Tol. D.C. | 4 | 0/1/4085 | 0/6/171078 | Likely pathogenic | DM | BL VUR | Variant inherited from father (mild facial dysmorphism) |
Cleft palate | ||||||||||||||
Facial dysmorphism | ||||||||||||||
Protruding ears | ||||||||||||||
Delayed development | ||||||||||||||
A4478l | FAT4g | Compound het | c.9279A>C | p.Gln3093His | Het | D. rerio | Tol. D.C. | 16 | / | 0/10/244826 | Likely pathogenic | DM | L RA, R UVJO | Yes (unaffected parents het carriers, variant confirmed in affected siblings) |
FAT4g | c.9313A>G | p.Ser3105Gly | Het | Xenopus tropicalis | Tol .D.C. | 4 | / | 0/5/245198 | Facial dysmorphism | |||||
Psychomotor delay | ||||||||||||||
Intellectual disability | ||||||||||||||
Hypotonia | ||||||||||||||
Sprengel deformity | ||||||||||||||
Other skeletal deformities | ||||||||||||||
BL cryptorchism | ||||||||||||||
A4672f,m | HNF1Bg | Dominant | c.1024T>C | p.Ser 342Pro | Het | D. rerio | 0.767 Del. D.C. | 8 | / | 0/1/243686 | Likely pathogenic | DM | R RHD | Variant inherited from mother (affection status unknown) |
Cystinuria | ||||||||||||||
A4732h | SRGAP1g | Dominant | c.806G>A | p.Cys 269Tyr | Het | D. rerio | 0.840 Tol. D.C. | 25 | / | / | Pathogenic | DM | R MCDK | Variant inherited from affected mother (R duplicated kidney) |
R ureterocele | ||||||||||||||
A3403n | TRAP1g | Recessive | c.1406G>A | p.Arg 469His | Hom | S. cerevisiaeo | 0.997 Del. D.C. | 33 | 0/66/4234 | 11/1552/269946 | Pathogenic | DM | BL VUR | Yes (unaffected parents het carriers, variant segregates in two affected siblings) |
A3880p | TBX18g | Dominant | c.1010delG | p.Gly 337Val fs*19i | Het | — | / | NA | / | / | Likely pathogenic | DM | UPJO | Yes (segregates in multiple affected family members) |
HAGq | NRIP1g | Dominant | c.279del | p.Trp 93* (stop gain)i | Het | — | / | NA | / | / | Likely pathogenic | DM | RHD | Yes (segregates in multiple affected family members) |
MCDK | ||||||||||||||
Hydronephrosis | ||||||||||||||
A1023r | FREM2g | Compound het | c.4031G>A | p.Arg 1344His | Het | D. rerio | 0.085 Del./ | 16 | 0/23/4277 | 12/102/277164 | Uncertain significance | DM | R RA | NA |
FREM2g | c.7535G>A | p.Arg 2512His | Het | D. rerio | 0.929 Del./ | 18 | 0/10/4290 | 0/132/276840 | Uncertain significance | DM | Bladder calculi | |||
A1220f | ROBO2g | Dominant | c.292G>T | p.Gly 98Trp | Het | C. elegans | 0.880 Del. D.C. | 19 | / | / | Uncertain significance | DM | R UPJO | NA |
Renal stones | ||||||||||||||
A1232r | FREM2g | Compound het | c.649C>T | p.Arg 217Cys | Het | X. tropicalis | 0.836 Del./ | 17 | / | 0/1/244270 | Uncertain significance | DM | PUV, R VUR, L UPJO | NA |
FREM2g | c.4031G>A | p.Arg 1344His | Het | D. rerio | 0.085 Del./ | 16 | 0/23/4277 | 12/102/277164 | Uncertain significance | DM | Progressive renal impairment | |||
B24s | ETV4g | Recessive | c.1244G>A | p.Arg 415His | Hom | Drosphilia melanogaster | 1.00 Del. D.C. | 36 | 0/1/4299 | 0/23/245730 | Likely pathogenic | Gene | R VUR | Variant het in unaffected mother, paternal DNA NA |
B196 | CTU2g | Recessive | c.1399C>T | p.Arg 467Cys | Hom | D. melanogastert | 0.926 Del. D.C. | 21 | / | 0/1/245354 | Likely pathogenic | Gene | L hydronephrosis | Variant het in unaffected mother, paternal DNA NA |
Facial dysmorphism | ||||||||||||||
Microcephaly | ||||||||||||||
Intellectual disability | ||||||||||||||
Growth retardation | ||||||||||||||
Pulmonary stenosis | ||||||||||||||
Imperforate anus | ||||||||||||||
Absent uterus | ||||||||||||||
B268u | HPSE2g | Recessive | c.457C>T | p.Arg 153*i | Hom | — | / | 10 | / | 0/3/245274 | Pathogenic | DM | Urofacial syndrome | NA |
L RHD, L UPJO | ||||||||||||||
A3837 | TBX18g | Dominant | c.1802A>G | p.Gln 601Arg | Het | Ciona intestinalis | 0.932 Del. D.C. | 14 | / | 0/4/217866 | Uncertain significance | Gene | PUV, BL VUR | NA |
A3900 | FRAS1g | Compound het | c.3998T>C | p.Val 1333Ala | Het | C. elegansv | 0.086 Tol. D.C. | 15 | / | 0/12/244984 | Uncertain significance | Gene | PUV | NA |
FRAS1g | c.8131T>C | p.Tyr 2711His | Het | C. elegans | 0.928 Del. D.C. | 13 | / | 1/29/191356 | Uncertain significance | Gene | ||||
B211 | Trisomy 18g | De novo dominant | — | / | / | R MCDK, L RHD | NA | |||||||
Facial dysmorphism | ||||||||||||||
Short palpebral fissures | ||||||||||||||
Very small low-set ears | ||||||||||||||
High arched palate | ||||||||||||||
Congenital cardiopathy | ||||||||||||||
Esophageal atresia and trachoesophageal fistula | ||||||||||||||
High position of the anus | ||||||||||||||
Generalized nail hypoplasia | ||||||||||||||
Syndactyly of the feet | ||||||||||||||
B630 | HNF1Bg | Dominant | 1.5-Mb deletion chromosome 17q12 | Pathogenic | DM | BL MCDK | NA | |||||||
Hyperuricemia ADHD | ||||||||||||||
Developmental delay | ||||||||||||||
B1434 | CTU2g | Recessive | c.1399C>T | p.Arg 467Cys | Hom | D. melanogasterw | 0.926 Del. D.C. | 21 | / | 0/1/245354 | Likely pathogenic | Gene | R MCDK, L hydronephrosis | NA |
Global developmental delay | ||||||||||||||
Brain MRI; cave of septum pellucidium | ||||||||||||||
B1435 | ACTG1g | De novo | c.464C>T | p.Ser 155Phe | Het | S. cerevisiae | 1.00 Del. D.C. | 18 | / | / | Pathogenic | DM | L partial duplex kidney, L hydroureter, L hydronephrosis, | NA |
Facial dysmorphism, lissencephaly, Dany–Walker malformation, global developmental delay | ||||||||||||||
Growth retardation | ||||||||||||||
B1439 | SALL1g | Dominant | c.1666G>A | p.Gly 556Ser | Het | D. rerio | 0.999 Del. D.C. | 20 | / | 0/3/245992 | Uncertain significance | Gene | BL VUR, BL hydronephrosis | NA |
B1316 | GREB1Lg | Dominant | c.4276G>A | p.Val 1426Ile | Het | D. rerioy | 0.079 Tol. D.C. | 14 | / | / | Likely pathogenic | Gene | BL RHD | NA |
Facial dysmorphism | ||||||||||||||
Short neck | ||||||||||||||
Single transverse palmar crease | ||||||||||||||
Brachydactyly | ||||||||||||||
A1261x | GREB1Lg | Dominant | c.5068G>A | p.Val1690Met | Het | X. tropicalis | 0.681 Del. D.C. | 30 | / | / | Likely pathogenic | Gene | BL VUR | Yes (segregates in multiple affected family members) |
L RA | ||||||||||||||
Supernumerary nipple | ||||||||||||||
F1436 | KAT6Bg | Dominant/de novo | c.4285G>A | p.Glu1429Lys | Het | D. rerio | 0.995 Tol. D.C. | 8 | / | / | Likely pathogenic | Gene | BL VUR, BL RHD | NA |
Facial dysmorphism | ||||||||||||||
Microcephaly | ||||||||||||||
Developmental delay | ||||||||||||||
Dysplastic ears | ||||||||||||||
Muscle weakness (pectoralis and trapezius with limited mobility of shoulder) | ||||||||||||||
B1650 | HPSE2g | Recessive | c.1099–2A>G | 100% ESS | Hom | — | / | NA | / | / | Pathogenic | Gene | Urofacial syndrome “inverted smile” | Yes (unaffected parents het carriers, variant segregates in two affected siblings) |
BL VUR | ||||||||||||||
Hinman syndrome | ||||||||||||||
A3962 | NPHP1z | Recessive | c.1804delA | p.Ser 602Val fs*4i | Hom | — | / | NA | / | 0/1/245974 | Pathogenic | Gene | BL RHD | NA |
A4235 | TMEM 231z | Recessive | c.119T>G | p.Leu40Arg | Hom | C. elegans | 0.951 Del. D.C. | 23 | / | / | Likely pathogenic | Gene | BL RHD, Facial dysmorphism, microcephaly, intellectual disability, polysyndactyly, heart anomalies, growth retardation. | Yes (segregates in two affected family members) |
B1306 | NPHP4z | Compound het | c.3983C>T | p.Pro1328Leu | Het | C. elegans | 0.999 Del. / | 26 | 0/4/2047 | 0/62/268266 | Likely pathogenic | Gene | BL RHD | NA |
NPHP4z | c.2021G>A | p.Arg674His | Het | C. elegans | 0.999 Del. / | 29 | 0/1/2089 | 0/8/277216 | Likely pathogenic | Gene | Growth retardation | |||
Patent ductus arteriosus | ||||||||||||||
Facial dysmorphism |
PP2, PolyPhen 2; SIFT, Sorting Intolerant from Tolerant; MT, Mutation Taster; CADD, Combined Annotation Dependent Depletion; EVS, Exome Variant Server; gnomAD, Genome Aggregation Database; ACMG, American College of Medical Genetics; Het, heterozygous; Del., deleterious; D.C., disease causing; /, data not available; DM, disease mutation; BL, bilateral; VUR, vesicoureteric reflux; R, right; L, left; MCDK, multicystic dysplastic kidney; —, not applicable; NA, not available; RA, renal agenesis; RHD, renal/hypodysplasia; Tol., tolerated; UVJO, ureterovesical junction obstruction; Hom, homozygous; UPJO, ureteropelvic junction obstruction; PUV, posterior urethral valve; ADHD, Attention Deficit Hyperactivity Disorder; Mb, megabase; MRI, magnetic resonance imaging; ESS, essential splice site.
For families in which the disease-causing variant has previously been reported in the literature, the corresponding reference is provided.
Evolutionary conservation was assessed across phylogeny over eight species: Mus musculus, Gallus gallus, Xenopus tropicalis, Danio rerio, Caenorhabditis elegans, Ciona intestinalis, Drosphilia melanogaster, and Saccharomyces cerevisiae. If conservation is interrupted in one species but otherwise preserved across phylogeny, additional information is provided.
Variant frequencies listed for homozygous/hemizygous (if applicable)/heterozygous/total alleles detected in the population.
ACMG American College of Human Genetics Standards and Guidelines Classification as pathogenic, likely pathogenic, or uncertain significance.66
HGMD, Human Gene Mutation Database; (https://portal.biobaseinternational.com/hgmd). If the exact variant has previously been reported and classified as a pathogenic mutation that is disease causing, the variant is denoted as DM. If the gene but not the exact variant has been reported for the corresponding phenotype, gene is indicated.
Ref. 42.
Mutations in the isolated or syndromic gene identified in families with the corresponding phenotype.
Ref. 21.
Frameshift, stop loss, stop gain, or nonsense variant.
Ref. 64.
Ref. 68.
Ref. 69.
Finding in more than two categories.
Ref. 36.
Interruption in conservation due to leucine present in C. intestinalis.
Ref. 23.
Ref. 43.
Ref. 33.
Ref. 32.
Interruption in conservation due to serine present in C. elegans.
Ref. 46.
Interruption in conservation due to arginine present in D. rerio.
Interruption in conservation due to serine present in C. elegans.
Ref. 44.
Interruption in conservation due to methionine present in M. musculus.
Mutations in phenocopy gene.